22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Employees - 56,
CEO - Mr. Lawrence D. Firestone,
Sector - Consumer Defensive,
Country - US,
Market Cap - 2.75M
Altman ZScore(max is 10): -26.27, Piotroski Score(max is 10): 5, Working Capital: $1560000, Total Assets: $21673000, Retained Earnings: $-393871000, EBIT: -13373000, Total Liabilities: $17661000, Revenue: $22203000
- Current Price $1.16 - Analyst Target Price $7192.80Ticker | XXII |
Index | - |
Curent Price | 1.16 |
Change | -10.77% |
Market Cap | 2.75M |
Average Volume | 919.97K |
Income | -25.47M |
Sales | 24.38M |
Book Value/Share | 5.49 |
Cash/Share | 2.08 |
Dividend Est | - |
Dividend TTM | - |
Dividend Ex-Date | - |
Employees | 56 |
Moving Avg 20days | -32.02% |
Moving Avg 50days | -56.28% |
Moving Avg 200days | -96.47% |
Shares Outstanding | 2.37M |
Earnings Date | Mar 20 BMO |
Inst. Ownership | 2.40% |
Price/Earnings | - |
Forwad P/E | - |
PE Growth | - |
Price/Sales | 0.11 |
Price/Book | 0.21 |
Price/Cash | 0.56 |
Price/FCF | - |
Quick Ratio | 0.95 |
Current Ratio | 1.16 |
Debt/Equity | 2.15 |
Return on Assets | -63.02% |
Return on Equity | -385.90% |
Return on Investment | -239.94% |
Gross Margin | -11.52% |
Ops Margin | -56.57% |
Profit Margin | -104.45% |
RSI | 25.65 |
BETA(β) | 1.92 |
From 52week Low | -6.45% |
From 52week High | -99.80% |
EPS | -518.20 |
EPS next Year | - |
EPS next Qtr | - |
EPS this Year | - |
EPS next 5 Year | - |
EPS past 5 Year | 52.01% |
Sales past 5 Year | 1.00% |
EPS Y/Y | 96.80% |
Sales Y/Y | -65.44% |
EPS Q/Q | 99.28% |
Sales Q/Q | -45.34% |
Sales Surprise | - |
EPS Surprise | - |
ATR(14) | 0.24 |
Perf Week | -19.44% |
Perf Month | -43.41% |
Perf Quarter | -78.15% |
Perf Year | -99.56% |
Perf YTD | -78.15% |
Target Price | 7192.80 |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer